Baseline serum syndecan-4 predicts prognosis after the onset of acute exacerbation of idiopathic interstitial pneumonia.

Yuki SatoYoshinori TaninoXintao WangTakefumi NikaidoSuguru SatoKenichi MisaRyuichi TogawaCharles W FrevertMitsuru Munakata

Published in: PloS one (2017)

Baseline serum syndecan-4 is a possible prognostic biomarker after the onset of acute exacerbation of idiopathic interstitial pneumonia.

Keyphrases